ICER releases draft evidence report on treatments for Duchenne muscular dystrophy

22 May 2019 - Public comment period now open until June 18, 2019; requests to make oral comment during public ...

Read more →

HHS marches forward to enhance drug price transparency

21 May 2019 - HHS Secretary Alex Azar has been almost singularly focused in delivering on the administration’s promises to ...

Read more →

Agile Therapeutics announces FDA acceptance of the NDA resubmission of Twirla

22 May 2019 - FDA assigns Prescription Drug User Fee Act goal date of 16 November 2019. ...

Read more →

FDA approves Sorilux for adolescent plaque psoriasis

22 May 2019 - Mayne Pharma is pleased to announce that the US FDA has approved Sorilux (calcipotriene) foam, 0.005% ...

Read more →

House Committee proposes 6% increase in FDA funding for FY 2020

22 May 2019 - The House Appropriations Committee on Wednesday released a draft fiscal year 2020 funding bill for the ...

Read more →

U.S. FDA grants priority review of Invokana (canagliflozin) sNDA for the treatment of chronic kidney disease in patients with type 2 diabetes

22 May 2019 - Application was submitted in March 2019 based on landmark phase 3 CREDENCE renal outcomes study published in ...

Read more →

Lilly selling half-price version of popular Humalog insulin

22 May 2019 - A half-price version of Eli Lilly's popular Humalog insulin is now available, following the company's promise in ...

Read more →

Guyon Espiner investigates PHARMAC: The NZ Buyer’s Club

23 May 2019 - Guyon Espiner reveals how lung cancer patients are buying cut-price drugs from India, as other New Zealanders ...

Read more →

Free market activists slam Trump's international drug pricing index

21 May 2019 - Rep. Andy Biggs: 'Seems to me like we're importing drug controls'. ...

Read more →

PolyPid receives a second QIDP designation for D-PLEX100 in abdominal surgery

21 May 2019 - PolyPid Ltd announced today that the United States FDA has granted a second qualified infectious disease product ...

Read more →

Official Information Act response: PrEP data

20 May 2019 - PHARMAC responds to a request for information relating to the funding of tenofovir disoproxil fumarate with ...

Read more →

Official Information Act response: adrenaline auto-injector cost utility analysis

20 May 2019 - PHARMAC responds to a request for any cost utility analyses performed by PHARMAC in relation to ...

Read more →

Roche’s breast cancer drug gains more insurance benefits

21 May 2019 - The Ministry of Health and Welfare has granted additional reimbursement to Roche’s breast cancer therapy Perjeta (pertuzumab) ...

Read more →

Louisiana is creating a drug price revolution

20 May 2019 - Louisiana is putting the final touches on a revolutionary deal that promises to simultaneously control health ...

Read more →

FDA replaces withdrawn biosimilar guidance with new one on quality-related considerations

21 May 2019 - A week after finalizing guidance on developing interchangeable biosimilars, the US FDA has drafted guidance for ...

Read more →